{
    "organizations": [],
    "uuid": "08cd9b2a52bc2cf0c592e6db9fbe0f7ba8c7e49b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-immuron-ltd-seeks-trading-halt/brief-immuron-ltd-seeks-trading-halt-idUSFWN1QO0QV",
    "ord_in_thread": 0,
    "title": "BRIEF-Immuron Ltd Seeks Trading Halt",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 7 (Reuters) - Immuron Ltd:\n* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON ‍RELEASE OF ITS PHASE II NASH CLINICAL TRIAL RESULTS​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-07T06:54:00.000+02:00",
    "crawled": "2018-03-07T19:46:13.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "immuron",
        "ltd",
        "seek",
        "trading",
        "halt",
        "pending",
        "announcement",
        "phase",
        "ii",
        "nash",
        "clinical",
        "trial",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}